Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...

Pulsed field ablation (PFA) has been embraced as a catheter ablation modality with potential to be safer for atrial ...

Atrial fibrillation (AF), the most common cardiac arrhythmia, affects approximately 3-6 million people in the United States — a figure expected to increase to around 6-16 million by 2050. Globally, ...

Please provide your email address to receive an email when new articles are posted on . Primary efficacy failure was defined as subsequent surgery or ablation treatment for AF; AF, atrial flutter or ...

OptiShot ultra-compliant balloon enables tissue contact and precise anatomic delivery of pulsed energy for treatment of atrial fibrillation in first European patients MARLBOROUGH, Mass.--(BUSINESS ...

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

Saint-Etienne, France - Radiofrequency ablation is more effective than treatment with amiodarone for the prevention of atrial flutter recurrence in patients who experienced a first symptomatic episode ...